Search hospitals
>
Virginia
>
Charlottesville
University of Virginia Cancer Center
Claim this profile
Charlottesville, Virginia 22903
Global Leader in Lung Cancer
Global Leader in Ovarian Cancer
Conducts research for Cancer
Conducts research for Breast Cancer
Conducts research for Brain Tumor
483 reported clinical trials
31 medical researchers
Summary
University of Virginia Cancer Center is a medical facility located in Charlottesville, Virginia. This center is recognized for care of Lung Cancer, Ovarian Cancer, Cancer, Breast Cancer, Brain Tumor and other specialties. University of Virginia Cancer Center is involved with conducting 483 clinical trials across 542 conditions. There are 31 research doctors associated with this hospital, such as William C. Petersen, Linda Duska, MD, Richard D. Hall, and Matthew J. Reilley.
Area of expertise
Lung Cancer
University of Virginia Cancer Center has run 70 trials for Lung Cancer. Some of their research focus areas include:
Ovarian Cancer
University of Virginia Cancer Center has run 66 trials for Ovarian Cancer. Some of their research focus areas include:
Top PIs
William C. Petersen
University of Virginia Cancer Center
6 years of reported clinical research
Linda Duska, MD
University of Virginia Cancer Center
6 years of reported clinical research
Richard D. Hall
University of Virginia Cancer Center
2 years of reported clinical research
Matthew J. Reilley
University of Virginia Cancer Center
1 year of reported clinical research
Clinical Trials running at University of Virginia Cancer Center
Lung Cancer
Cancer
Ovarian Cancer
Skin Cancer
Non-Small Cell Lung Cancer
Uterine Cancer
Breast Cancer
Prostate Cancer
Brain Tumor
Wilms Tumor
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Thoracotomy vs Thoracoscopy
for Metastatic Osteosarcoma
This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.
Recruiting
2 awards
Phase 3
7 criteria
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting
2 awards
Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Virginia Cancer Center?
University of Virginia Cancer Center is a medical facility located in Charlottesville, Virginia. This center is recognized for care of Lung Cancer, Ovarian Cancer, Cancer, Breast Cancer, Brain Tumor and other specialties. University of Virginia Cancer Center is involved with conducting 483 clinical trials across 542 conditions. There are 31 research doctors associated with this hospital, such as William C. Petersen, Linda Duska, MD, Richard D. Hall, and Matthew J. Reilley.
Where is University of Virginia Cancer Center located?
To visit the Emily Couric Clinical Cancer Center, located at 1240 Lee St, Charlottesville, VA 22903, you can take U.S. 29 or I-64. Parking is available at the Lee Street Parking Garage, where you can validate your ticket for free parking.
Who should I call to ask about financial aid or insurance network?
**University of Virginia Cancer Center Financial Assistance and Insurance Support** - **Financial Assistance:** Patients in need can contact UVA Financial Aid at 434.924.8718 or 866.320.9659 (toll-free), or email financialassistance@virginia.edu. Eligibility for financial aid is determined using a sliding scale based on assets, income, and household size. A financial aid calculator is available to estimate eligibility. - **Insurance Support:** For insurance inquiries, contact UVA Finance at askfinance@virginia.edu. Coverage includes aircraft, professional liability, restitution and recovery for departmental damage, and automobile physical damage insurance. - **Eligibility for Financial Assistance Program:** Offers a 100 percent discount or free care for medically necessary services to eligible patients. Criteria include being uninsured or underinsured, unable to access other coverage programs, having an annual family income within 300 percent of the Federal Poverty Guidelines, not possessing substantial cash assets, and residing within a 25-mile radius of the service facility.
What insurance does University of Virginia Cancer Center accept?
The University of Virginia Cancer Center accepts a wide range of insurance plans, including government programs (Medicaid, Medicare), Medicaid HMOs (Aetna Better Health, Anthem Healthkeepers Plus, Molina Healthcare, Sentara Community Plan, United Healthcare Community Plan, Virginia Premier), and commercial health plans (Aetna, Anthem, CIGNA, MedCost/Virginia Health Network, Multiplan/PHCS, Sentara Health Plan, Oscar Exchange, Piedmont Community Health Plan, United Healthcare). They also participate in Medicare Advantage Plans (Part C) such as Aetna, Anthem, Cigna Medicare, Clear Spring Health, Humana, Molina Healthcare, Sentara Health Plan, United, and Virginia Premier. Please verify participation, coverage levels, and benefit criteria with your health plan authorized representative prior to receiving services.
What awards or recognition has University of Virginia Cancer Center received?
The University of Virginia Cancer Center, located in Charlottesville, Virginia, is a National Cancer Institute-designated Comprehensive Cancer Center, recognized for its exceptional cancer program. It has been named a "high performing" cancer service by U.S. News & World Report, excelling in lung, colon, and ovarian cancer surgery. Annually, the center secures over $55 million in funded research, significantly advancing cancer treatment through research and clinical trials.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.